Prostate Cancer - Results from #20

First-line pembrolizumab plus androgen deprivation therapy for locally advanced microsatellite instability-high prostate cancer in a patient with Muir-Torre syndrome: A case report. March 22, 2023

Radical prostatectomy trends between 2010 and 2020 in Ehime, Japan, identified using data from the Medical Investigation Cancer Network (MICAN) study. March 22, 2023

Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRT. March 22, 2023

Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions. March 22, 2023

RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis. March 22, 2023

Value Based Payment Shift for Independent Urology Practices: Roadmap and Barriers March 21, 2023

Artera Launches with $90 Million in Funding to Personalize Cancer Therapy with Multimodal AI March 21, 2023

Disparities in Genitourinary Cancers Incidence and Mortality in the United States - Expert Commentary March 21, 2023

Taxanes Versus Androgen Receptor Therapy as Second-Line Treatment for Castrate-Resistant Metastatic Prostate Cancer After First-Line Androgen Receptor Therapy. March 21, 2023

Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapy. March 21, 2023

Guidelines for Sexual Health Care for Prostate Cancer Patients: Recommendations of an International Panel. March 21, 2023

Nutrition Guidance for Patients on Androgen Deprivation Therapy. March 21, 2023

Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2). March 21, 2023

Contemporary patterns of local ablative therapies for prostate cancer at United States cancer centers: results from a national registry. March 21, 2023

Incorporating radioligand therapy in clinical practice in the United States for patients with prostate cancer. March 21, 2023

Prostate-speciﬁc antigen response after Abiraterone treatment in mCRPC: PSA as a predictor of overall survival. March 20, 2023

Patient Perceptions of a Decision Support Tool for Men with Localized Prostate Cancer. March 20, 2023

Experiences of Men With Prostate Cancer Participating in a Clinical Pathway With a Supervised Group-based Exercise Program to Combat Androgen Deprivation-Induced Side Effects: A Qualitative Focus Group Study. March 20, 2023

Convolutional Neural Network Quantification of Gleason Pattern 4 and Association with Biochemical Recurrence in Intermediate Grade Prostate Tumors. March 20, 2023

Next Generation Radiotheranostics Promoting Precision Medicine. March 20, 2023

Page 2 of 1288